Oligonucleotide and artificial nucleoside having guanidine bridge

US10377789B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10377789-B2
Application numberUS-201314428646-A
CountryUS
Kind codeB2
Filing dateSep 19, 2013
Priority dateSep 21, 2012
Publication dateAug 13, 2019
Grant dateAug 13, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A compound represented by formula I or II below or a salt thereof: wherein B 1 represents a purin-9-yl group or a 2-oxo-1,2-dihydropyrimidin-1-yl group that has any one or more substituents selected from the group consisting of a hydroxyl group, a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, an amino group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound represented by formula I or II below or a salt thereof: wherein B 1 represents: a purin-9-yl group; a 2-oxo-1,2-dihydropyrimidin-1-yl group; a purin-9-yl group that has any one or more substituents selected from the group consisting of a hydroxyl group, a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, an amino group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom; a 2-oxo-1,2-dihydropyrimidin-1-yl group that has any one or more substituents selected from the group consisting of a hydroxyl group, a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, an amino group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom; R 1 , R 12 , and R 13 each independently represent a hydrogen atom, a C 1 to C 7 alkyl group that is a straight chain, a branched chain or up to a C 7 ring, a protecting group for an amino group, or and R 2 and R 3 each independently represent a hydrogen atom, a protecting group for a hydroxyl group in nucleic acid synthesis, a C 1 to C 7 alkyl group that is a straight chain, a branched chain or up to a C 7 ring, a C 2 to C 7 alkenyl group that is a straight chain, a branched chain or up to a C 7 ring, a C 6 to C 12 aryl group, a C 6 to C 12 aryl group that has any one or more substituents selected from the group consisting of a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom, a C 6 to C 12 aryl group that has any one or more substituents selected from the group consisting of a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom, an aralkyl group having a C 6 to C 12 aryl moiety, an aralkyl group having a C 6 to C 12 aryl moiety that has any one or more substituents selected from the group consisting of a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom, an aralkyl group having a C 6 to C 12 aryl moiety, an aralkyl group having a C 6 to C 12 aryl moiety that has any one or more substituents selected from the group consisting of a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a mercapto group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkylthio group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom, an acyl group that has any one or more substituents selected from the group consisting of a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, a C 1 to C 6 linear alkylthio group, a C 1 to C 6 linear alkylamino group, an amino group protected by a protecting group in nucleic acid synthesis, and a halogen atom, a silyl group that has three substituents selected from the group consisting of a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 6 linear alkyl group, a C 1 to C 6 linear alkoxy group, and an amino group protected by a protecting group in nucleic acid synthesis, a phosphate group, a phosphate group that has any one or more substituents selected from the group consisting of a C 1 to C 6 linear alkyl group, and a C 1 to C 6 linear alkoxy group, a phosphate group protected by a protecting group in nucleic acid synthesis, or —P(R 4 )R 5 , wherein R 4 and R 5 each independently represent a hydroxyl group protected by a protecting group in nucleic acid synthesis, a C 1 to C 5 alkoxy group, a C 1 to C 6 cyanoalkoxy group, or a dialkylamino group substituted with a two C 1 to C 6 alkyl groups, wherein the protecting group in nucleic acid synthesis is a C 1 to C 6 alkyl group; a C 1 to C 6 alkenyl group; an acyl group; a tetrahydropyranyl group or a tetrahydrothiopyranyl group; a tetrahydrofuranyl group or a tetrahydrothiofuranyl group; a methyl group substituted with a C 1 to C 6 alkoxy group; a methyl group substituted with a C 1 to C 6 alkoxy group substituted with a C 1 to C 6 alkoxy group; a methyl group substituted with a C 1 to C 6 alkoxy group substituted with a halogen atom; an ethyl group substituted with a C 1 to C 6 alkoxy group; an ethyl group substituted with a halogen atom; a methyl group substituted with one to three aryl groups; a methyl group substituted with one to three aryl groups substituted with at least one substituent selected from the group consisting of a C 1 to C 6 alkyl group, a C 1 to C 6 alkoxy group, a halogen atom, and a cyano group; a carbonyl group substituted with a C 1 to C 6 alkoxy group; an aryl group substituted with at least one substituents selected from the group consisting of a halogen atom, a C 1 to C 6 alkoxy group, and a nitro group; a carbonyl group substituted with a C 1 to C 6 alkoxy group substituted with at least one substituent selected from the group consisting of a halogen atom and a silyl group substituted with three C 1 to C 6 alkyl groups; an alkenyloxycarbonyl group; or an aralkyloxycarbonyl group substituted with an aryl group substituted with at least one substituent selected from the group consisting of a C 1 to C 6 alkoxy group and a nitro group; wherein the protecting group for a hydroxyl group in nucleic acid synthesis is an aliphatic acyl group; an aromatic acyl group; a methyl group substituted with one to three aryl groups; a methyl group substituted with one to three aryl groups substituted with at least one substituent selected from the group consisting of a C 1 to C 6 alkyl group, a C 1 to C 6 alkoxy group, a halogen atom, a cyano group and a trialkyl substituted silyl group; and wherein the protecting group for an amino group is an acyl group, a benzoyl group, a tert-butoxycarbonyl group, or a 9-fluorenylmethyloxycarbonyl group; and with the proviso that substituents specified in all chemical structures by each of the terms —OH (hydroxyl group), mercapto group (—SH), a C 1 to C 6 linear alkylamino group, a phosphate group, and

Assignees

Inventors

Classifications

  • Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00) · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

  • C07H19/06Primary

    Pyrimidine radicals · CPC title

  • C07H19/10Primary

    with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10377789B2 cover?
A compound represented by formula I or II below or a salt thereof: wherein B 1 represents a purin-9-yl group or a 2-oxo-1,2-dihydropyrimidin-1-yl group that has any one or more substituents selected from the group consisting of a hydroxyl group, a hydroxyl group protect…
Who is the assignee on this patent?
Univ Osaka
What technology area does this patent fall under?
Primary CPC classification C07H19/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).